# clm_7EE1B4067292

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: total_equity  
value: 15,589,200,000 United States dollar  
valid_from: 2016-09-30  
valid_to: 2016-12-31  
published: 2016-10-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_0A273F2F1080  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company total equity: 15,589,200,000 United States dollar", as of 2016-09-30 (until 2016-12-31). Claim clm_7EE1B4067292, https://asof.is/claim/clm_7EE1B4067292, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947816000440/0000059478-16-000440-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2016, filed 2016-10-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947816000440/0000059478-16-000440-index.htm (primary, SEC EDGAR 10-Q Q3 FY2016, published 2016-10-28)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | total_equity | 14,637,300,000 United States dollar | valid 2016-06-30 to 2016-09-30 | conf 0.95 | superseded | superseded_by [clm_7EE1B4067292](/claim/clm_7EE1B4067292.md) | [clm_C85B54CB3609](/claim/clm_C85B54CB3609.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.
